𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PSS15 THE COST-EFFECTIVENESS OF RANIBIZUMAB (LUCENTIS®) IN TREATING PATIENTS WITH PREDOMINANTLY CLASSIC, MINIMALLY CLASSIC, AND OCCULT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (AMD)

✍ Scribed by A Turpcu; JW Hay


Book ID
118609604
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
89 KB
Volume
11
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES